Nuclear Medicine/Radiopharmaceuticals Market Dynamics
Exploring Growth Opportunities and Technological Advances

Delvens published a new research publication on "Nuclear Medicine/Radiopharmaceuticals
Market Insights,
to 2030" with self-explained Tables and charts in presentable format. In
the Study you will find new evolving Trends, Drivers, Restraints, Opportunities
generated by targeting market associated stakeholders. The growth of the Nuclear
Medicine/Radiopharmaceuticals Market was mainly driven by the increasing
R&D spending across the world, the Nuclear Medicine/Radiopharmaceuticals
Market size is projected to reach a CAGR of 10.1% to 2030.

Get Free Sample
Report: https://www.delvens.com/get-free-sample/radiopharmaceuticals-market

Radiopharmaceuticals are pharmaceutical formulations
comprising radioactive isotopes that are used in diagnosis and therapeutics.
They are simple and small substances that contain a radioactive substance that
is used in the treatment of cancer and cardiac & neurological disorders.

Increasing incidence and prevalence of cancer and cardiac
ailments and initiatives to lessen the demand-supply gap of Mo-99 are some of
the factors that have supported long-term expansion for Nuclear
Medicine/Radiopharmaceuticals Market.

Regional Analysis

North America is expected to account for the largest share
of the nuclear medicine market during the forecast period, the large share of
North America can be attributed to the development of novel technologies for
radioisotope production, government funding, increasing R&D expenditure and
company initiatives in the region.

Recent Developments

In 2021, Bracco
entered into a partnership with CardioNavix which will help improve patient
access to cardiac PET imaging.

In 2019, Curium
acquired MAP Medical, which will help it to increase its footprint in Europe
with direct access to Nordic and Baltic countries.

Key Players of Nuclear Medicine/Radiopharmaceuticals
Market

·       
Mallinckrodt plc.

·       
General Electric Co. (healthcare division)

·       
Medtronic, Inc.

·       
Bayer AG

·       
Cardinal Health, Inc.

·       
Lantheus Medical Imaging, Inc.

·       
IBA Group and More

Reasons to Acquire

·       
Increase your understanding of the market for
identifying the best and suitable strategies and decisions on the basis of
sales or revenue fluctuations in terms of volume and value, distribution chain
analysis, market trends and factors

·       
Gain authentic and granular data access for
Nuclear Medicine/Radiopharmaceuticals Market so as to understand the trends and
the factors involved behind changing market situations

·       
Qualitative and quantitative data utilization to
discover arrays of future growth from the market trends of leaders to market
visionaries and then recognize the significant areas to compete in the future

·       
In-depth analysis of the changing trends of the
market by visualizing the historic and forecast year growth patterns

In addition to the
market data for Nuclear Medicine/Radiopharmaceuticals Market, Delvens offers
client-centric report and customized according to the company’s specific demand
and requirement.

More Related Reports:

Animal Antibiotics and Antimicrobials
Market

Cosmetics Market

About Us:

Delvens is a strategic advisory and consulting company
headquartered in New Delhi, India. The company holds expertise in providing
syndicated research reports, customized research reports and consulting
services. Delvens qualitative and quantitative data is highly utilized by each
level from niche to major markets, serving more than 1K prominent companies by
assuring to provide the information on country, regional and global business
environment. We have a database for more than 45 industries in more than 115+
major countries globally.

Delvens database assists the clients by providing in-depth
information in crucial business decisions. Delvens offers significant facts and
figures across various industries namely Healthcare, IT & Telecom,
Chemicals & Materials, Semiconductor & Electronics, Energy,
Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our
company provides an exhaustive and comprehensive understanding of the business
environment.

Contact us:

Unit No. 01, 3rd Floor, Plot No. 56, Block B

Sector 2 Noida, Near Noida Sector 15 Metro Station 201301,
IN

+44 20 3290 6466

+0120- 4903958

sales@delvens.com